This Disease Hikes Health Care Costs By More than $10,000 a Year
Medical professionals and economists have been worried about the growing prevalence of diabetes for years. A new report shows their concerns are well placed. In 2013, the per capita health care bills of consumers with diabetes was $15,000, nearly 71 percent ($10,700) higher than those without the disease, according to the Healthcare Cost Institute.
The brunt of those bills are borne by health care providers, but consumers with diabetes have per capita out-of-pocket costs of $1,922, compared to just $738 for those who do not have diabetes.
For those under the age of 65, health care expenses grew an average 4.1 percent from 2012 to 2013, but the increase was even higher among children, who saw expenses rise 7 percent from 2011 to 2012 and then another 9.6 percent from 2012 to 2013.
Related: Diabetes Detection Up in Pro-Obamacare States
“There has been extraordinary growth in health spending for children with diabetes,” HCCI senior research Amanda Frost said in a statement, citing branded insulin as one factor in the increase.
For children, the costs go beyond medication. A 2012 study in Health Affairs found that people who develop diabetes before age 30 make less money than their peers, are more likely to drop out of high school and less likely to attend college.
One of the most widespread chronic diseases in the United States, diabetes care consumes about 10 percent of U.S. health care spending, according to a study by the University of Michigan.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
